New Sensor Design Reduces Interruptions and Improves Glucose Control in Adolescents

Researchers compared how adolescents with type 1 diabetes performed when using two different continuous glucose monitoring sensors with the Minimed 780G automated insulin pump system. The study included 42 adolescents (median age 12 years) who had been using automated insulin delivery for at least 6 months. They looked at the final two weeks of using the Guardian 4 sensor and compared it to the final two weeks after switching to the new Simplera Sync sensor. All measurements were taken during the school term, and no pump settings were changed during the comparison.

The new Simplera Sync sensor has an all-in-one design that doesn't require a separate rechargeable transmitter. This design feature allows for overlapping sensor transitions—meaning a new sensor can be started before the old one expires, reducing gaps in glucose monitoring coverage.

One of the most significant findings was an increase in time spent in automated mode. With the Guardian 4 sensor, adolescents were in automated mode 95.3% of the time. After switching to Simplera Sync, this increased to 97.1%—about 23 additional minutes per day. This improvement was statistically significant, meaning it was unlikely to have occurred by chance.

The increase in automated mode time likely reflects fewer interruptions caused by sensor transitions. Because the new sensor's all-in-one design eliminates the need to recharge a transmitter, there may be fewer moments when the system temporarily switches out of automation.

Glucose control showed modest but meaningful improvements. Time in target range (70–180 mg/dL) increased from 76.7% to 79.3%, and average glucose dropped from 146.0 to 141.3 mg/dL. Time spent above 250 mg/dL—a level associated with higher risk of complications—decreased from 3.0% to 2.0%.

Importantly, these improvements occurred without any increase in low blood sugar events (hypoglycemia). This finding is significant because it shows the system worked better without introducing new safety concerns.

Beyond the numbers, adolescents reported meaningful quality-of-life improvements. Treatment satisfaction increased and perceived device burden decreased after switching to Simplera Sync. These patient-reported outcomes matter because living with type 1 diabetes involves more than glucose numbers—it includes the daily weight of managing devices and treatment routines.

The fully disposable sensor design appears to reduce this burden by eliminating the step of recharging a transmitter. For busy adolescents managing school, activities, and diabetes care, fewer interruptions can make a real difference in daily life.

This study was a real-world retrospective analysis, which means researchers looked back at actual patient data rather than conducting a controlled trial. The authors note that prospective validation—a study designed specifically to test this sensor and system combination—would help confirm these findings in a larger population.

The results suggest that thoughtful sensor design choices, like the all-in-one approach and overlapping transitions, can reduce practical interruptions in automated insulin delivery while maintaining or improving glucose control. Future research will help clarify which design features matter most and how they translate across different age groups and settings.

Source: Diabetes research and clinical practice. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.